This screening is a fundamental safety measure and should be documented in the patient's medical records
Nicola Veronese, Brendon Stubbs, Marco Solmi, Oltarget="_blank" rel="noopener"esya Ajnakina, Andre F Carvalho, Stefania Maggi, 2018 Feb - Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors
893 Amikishieva, K
However, it's always recommended to consult with a healthcare professional before starting any new supplement regimen, especially if you have underlying health conditions or are pregnant or nursing
Aksenov MY, Markesbery WR (2001) Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimers disease
Retrieved 22 April 2022, from